Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer

MiR-210 is the master hypoxamir that generally exhibits oncogenic properties in most human solid tumors including bladder cancer (BC). However, it remains unknown about the clinical significance of circulating miR-210 levels in BC. In this study, we found that serum miR-210 was up-regulated in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yongmei, Qu, Ailin, Liu, Jingkang, Wang, Rui, Liu, Yingjie, Li, Gang, Duan, Weili, Fang, Qian, Jiang, Xiumei, Wang, Lili, Zheng, Guixi, Du, Lutao, Zhang, Xin, Wang, Chuanxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529273/
https://www.ncbi.nlm.nih.gov/pubmed/26252880
http://dx.doi.org/10.1371/journal.pone.0135168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529273/
https://www.ncbi.nlm.nih.gov/pubmed/26252880
http://dx.doi.org/10.1371/journal.pone.0135168

Ejemplares similares